Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder[L6010,Label].
Synonyms
Dexamfetamina
Dextroamphetamine saccharate
Dexanfetamina
Dextroamphetamine sulfate
(S)-(+)-β-phenylisopropylamine
(S)-(+)-amphetamine
Dexamphetamine
(S)-1-phenyl-2-aminopropane
(S)-1-phenyl-2-propylamine
Dexamfetamine
(+)-(S)-amphetamine
(+)-amphetamine
Dextroamphetamine
(S)-α-methylbenzeneethanamine
Dextroamphetamine adipate
(S)-amphetamine
Dexamfetaminum
(+)-α-methylphenylethylamine
Desamfetamina
(αS)-α-methylbenzeneethanamine
(+)-α-methylphenethylamine
d-amphetamine
Brand Names
Dextroamphetamine
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682